Clinical trialPhase 2Completed
Trial to Investigate Intensified Neoadjuvant Chemotherapy in Locally Advanced Pancreatic Cancer
Prospective Randomized Multicenter Phase II Trial to Investigate Intensified Neoadjuvant Chemotherapy in Locally Advanced Pancreatic Cancer
- Outcome
- Finished, no results posted
- Phase
- Phase 2
- Status
- Completed
- Study type
- Interventional
- Start
- November 2014
- Expected end
- 19 February 2020
- Enrollment
- 168 participants
- Sites
- 1
- Primary outcomes
- Conversion Rate
- Sponsor
- Other
- Results posted
- No
- Last update
- 15 December 2021
These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try
Papers 3
- Builds on itCirculating free bacterial DNA as a novel biomarker for monitoring therapy response in patients with advanced pancreati… DOI 10.1016/j.ejca.2026.117040↗
- Builds on itPrognostic and predictive value of CA 19-9 in locally advanced pancreatic cancer treated with multiagent induction chem… DOI 10.1016/j.esmoop.2022.100552↗
- Builds on itNab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in… DOI 10.1016/s2468-1253(20)30330-7↗